These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 19233257)

  • 1. Towards high-throughput identification of endocrine disrupting compounds with mass spectrometry.
    Bovet C; Plet B; Ruff M; Eiler S; Granger F; Panagiotidis A; Wenzel R; Nazabal A; Moras D; Zenobi R
    Toxicol In Vitro; 2009 Jun; 23(4):704-9. PubMed ID: 19233257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring ligand modulation of protein-protein interactions by mass spectrometry: estrogen receptor alpha-SRC1.
    Bovet C; Ruff M; Eiler S; Granger F; Wenzel R; Nazabal A; Moras D; Zenobi R
    Anal Chem; 2008 Oct; 80(20):7833-9. PubMed ID: 18778086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen receptor-ligand complexes measured by chip-based nanoelectrospray mass spectrometry: an approach for the screening of endocrine disruptors.
    Bovet C; Wortmann A; Eiler S; Granger F; Ruff M; Gerrits B; Moras D; Zenobi R
    Protein Sci; 2007 May; 16(5):938-46. PubMed ID: 17400923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ligand-induced changes in estrogen receptor conformation as measured by site-directed spin labeling.
    Hurth KM; Nilges MJ; Carlson KE; Tamrazi A; Belford RL; Katzenellenbogen JA
    Biochemistry; 2004 Feb; 43(7):1891-907. PubMed ID: 14967030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of receptor-binding assays and designed mutant receptors for discerning agonists and antagonists.
    Matsui K
    J Pharm Biomed Anal; 2007 Feb; 43(3):822-8. PubMed ID: 17141447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of a robust model protocol with accelerated throughput for a human recombinant full length estrogen receptor-alpha binding assay: protocol optimization and intralaboratory assay performance as initial steps towards validation.
    Freyberger A; Wilson V; Weimer M; Tan S; Tran HS; Ahr HJ
    Reprod Toxicol; 2010 Aug; 30(1):50-9. PubMed ID: 20074635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small-angle X-ray scattering studies on structures of an estrogen-related receptor alpha ligand binding domain and its complexes with ligands and coactivators.
    Jin KS; Park JK; Yoon J; Rho Y; Kim JH; Kim EE; Ree M
    J Phys Chem B; 2008 Aug; 112(32):9603-12. PubMed ID: 18646811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of the estrogen receptor Cd-binding sites by chemical modification.
    Nesatyy VJ; Rutishauser BV; Eggen RI; Suter MJ
    Analyst; 2005 Jul; 130(7):1087-97. PubMed ID: 15965534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterisation of bioactive compounds in infant formulas using immobilised recombinant estrogen receptor-alpha affinity columns.
    Riu A; Balaguer P; Perdu E; Pandelova M; Piccinelli R; Gustafsson JA; Leclercq C; Schramm KW; Dagnino S; Debrauwer L; Cravedi JP; Zalko D
    Food Chem Toxicol; 2008 Oct; 46(10):3268-78. PubMed ID: 18692112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring interactions of endocrine-disrupting compounds with different conformations of the human estrogen receptor alpha ligand binding domain: a molecular docking study.
    Celik L; Davey J; Lund D; Schiøtt B
    Chem Res Toxicol; 2008 Nov; 21(11):2195-206. PubMed ID: 18921983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ab initio quantum mechanical study of the binding energies of human estrogen receptor alpha with its ligands: an application of fragment molecular orbital method.
    Fukuzawa K; Kitaura K; Uebayasi M; Nakata K; Kaminuma T; Nakano T
    J Comput Chem; 2005 Jan; 26(1):1-10. PubMed ID: 15521089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic profiling of endocrine-disrupting compounds by on-line cytochrome p450 bioreaction coupled to on-line receptor affinity screening.
    Van Liempd SM; Kool J; Meerman JH; Irth H; Vermeulen NP
    Chem Res Toxicol; 2007 Dec; 20(12):1825-32. PubMed ID: 17975887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extending matrix-assisted laser desorption/ionization triple quadrupole mass spectrometry enzyme screening assays to targets with small molecule substrates.
    Rathore R; Corr JJ; Lebre DT; Seibel WL; Greis KD
    Rapid Commun Mass Spectrom; 2009 Oct; 23(20):3293-300. PubMed ID: 19757451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel method for evaluation of chemicals based on ligand-dependent recruitment of GFP labeled coactivator to estrogen receptor displayed on bacterial magnetic particles.
    Yoshino T; Kaji C; Nakai M; Saito F; Takeyama H; Matsunaga T
    Anal Chim Acta; 2008 Sep; 626(1):71-7. PubMed ID: 18761123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and purification of the ligand-binding domain of peroxisome proliferator-activated receptor alpha (PPARalpha).
    Müller MQ; Roth C; Sträter N; Sinz A
    Protein Expr Purif; 2008 Dec; 62(2):185-9. PubMed ID: 18755277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between the results of in vitro receptor binding assay to human estrogen receptor alpha and in vivo uterotrophic assay: comparative study with 65 selected chemicals.
    Akahori Y; Nakai M; Yamasaki K; Takatsuki M; Shimohigashi Y; Ohtaki M
    Toxicol In Vitro; 2008 Feb; 22(1):225-31. PubMed ID: 17904329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of human plasma lipids and soybean lecithin by means of high-performance thin-layer chromatography and matrix-assisted laser desorption/ionization mass spectrometry.
    Stübiger G; Pittenauer E; Belgacem O; Rehulka P; Widhalm K; Allmaier G
    Rapid Commun Mass Spectrom; 2009 Sep; 23(17):2711-23. PubMed ID: 19639618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterobifunctional isotope-labeled amine-reactive photo-cross-linker for structural investigation of proteins by matrix-assisted laser desorption/ionization tandem time-of-flight and electrospray ionization LTQ-Orbitrap mass spectrometry.
    Krauth F; Ihling CH; Rüttinger HH; Sinz A
    Rapid Commun Mass Spectrom; 2009 Sep; 23(17):2811-8. PubMed ID: 19653199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triple bioaffinity mass spectrometry concept for thyroid transporter ligands.
    Aqai P; Fryganas C; Mizuguchi M; Haasnoot W; Nielen MW
    Anal Chem; 2012 Aug; 84(15):6488-93. PubMed ID: 22741556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of covalent attachment site of antiestrogenic estradiol 11 beta-derivatives on human estrogen receptor alpha ligand-binding domain.
    Aliau S; Mattras H; Borgna JL
    J Steroid Biochem Mol Biol; 2006 Feb; 98(2-3):111-21. PubMed ID: 16439113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.